BoostDM

Model	BoostDM class	BoostDM score
(AML) Acute myeloid leukemia	Passenger	0.22
(BLCA) Bladder cancer	Driver	1.00
(BRCA) Breast adenocarcinoma	Driver	1.00
(CH) Cholangiocarcinoma	Driver	0.93
(CLL) Chronic lymphoblastic leukemia	Passenger	0.45
(CM) Cutaneous melanoma of the skin	Passenger	0.35
(COREAD) Colorectal adenocarcinoma	Driver	1.00
(DLBCL) Diffuse large B-cell lymphoma	Passenger	0.50
(ESCA) Esophageal cancer	Driver	1.00
(GBM) Glioblastoma	Driver	0.96
(HC) Hepatic cancer	Driver	0.58
(HGG) High-grade glioma	Passenger	0.07
(HNSC) Head and neck squamous cell carcinoma	Driver	0.99
(LEIS) Leiomyosarcoma	Passenger	0.08
(LGG) Lower grade glioma	Passenger	0.00
(LUAD) Lung adenocarcinoma	Passenger	0.15
(LUNG_CANCER) Lung cancer	Driver	0.76
(LUSC) Lung squamous cell carcinoma	Passenger	0.15
(LY) Lymphoma	Passenger	0.34
(MM) Multiple myeloma	Passenger	0.13
(NHLY) Non-hodking lymphoma	Driver	0.63
(OS) Osteosarcoma	Passenger	0.23
(OV) Ovary cancer	Driver	0.95
(PAAD) Pancreas adenocarcinoma	Passenger	0.11
(PIA) Pilocityc astrocytoma	Passenger	0.00
(PRAD) Prostate adenocarcinoma	Driver	0.52
(R) Kidney cancer	Driver	0.89
(RCCC) Renal clear cell carcinoma	Driver	0.89
(RCH) Chromophobe renal cell carcinoma	Passenger	0.35
(S) Sarcoma	Passenger	0.08
(SCLC) Small-cell lung cancer	Passenger	0.03
(ST) Stomach adenocarcinoma	Passenger	0.23
(UCEC) Endometrial cancer	Driver	0.99
(UCS) Uterine carcinosarcoma	Passenger	0.29

Select a tumor type to check the corresponding model Show the legend

Predictions cast with a model trained in this specific tumor type.

Predictions cast with a model trained with a more general tumor type, determined as the most recent underlined ancestor of the leaf.

Driver
The mutation is predicted to be a driver in this tumor type context.

Passenger
The mutation is predicted to be a passenger in this tumor type context.

(CANCER) Cancer
- (SOLID) Solid tumour
  - (S) Sarcoma
  - (UCEC) Endometrial cancer
    
    Driver
  - (ST) Stomach adenocarcinoma
    
    Passenger
  - (LUNG_CANCER) Lung cancer
    - (SCLC) Small-cell lung cancer
      
      Passenger
    - (NSCLC) Non-small cell lung cancer
      - (LUSC) Lung squamous cell carcinoma
        
        Passenger
      - (LUAD) Lung adenocarcinoma
        
        Passenger
  - (R) Kidney cancer
    - (RCH) Chromophobe renal cell carcinoma
      
      Passenger
    - (RCCC) Renal clear cell carcinoma
      
      Driver
  - (PRAD) Prostate adenocarcinoma
    
    Driver
  - (CNS) Central nervous system cancer
    - (G) Glioma
  - (PA) Pancreatic cancer
    - (PAAD) Pancreas adenocarcinoma
      
      Passenger
  - (OV) Ovary cancer
    
    Driver
  - (HNSC) Head and neck squamous cell carcinoma
    
    Driver
  - (LIVER) LIVER
    - (HC) Hepatic cancer
      
      Driver
  - (ESCA) Esophageal cancer
    
    Driver
  - (COREAD) Colorectal adenocarcinoma
    
    Driver
  - (SKIN) Skin cancer
    - (CM) Cutaneous melanoma of the skin
      
      Passenger
  - (CH) Cholangiocarcinoma
    
    Driver
  - (BRCA) Breast adenocarcinoma
    
    Driver
  - (BLCA) Bladder cancer
    
    Driver
- (NON_SOLID) Non-Solid cancer
  - (L) Lymphoid cancer
    - (LY) Lymphoma
      - (NHLY) Non-hodking lymphoma
        
        Driver
      - (DLBCL) Diffuse large B-cell lymphoma
        
        Passenger
    - (LK) Leukemia
      - (CLL) Chronic lymphoblastic leukemia
        
        Passenger
      - (AML) Acute myeloid leukemia
        
        Passenger
  - (MM) Multiple myeloma
    
    Passenger

Driver potential